Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.

ABSTRACT:

SUBMITTER: Spiliotis II 

PROVIDER: S-EPMC9543075 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature